Polymorphisms Within the Interleukin‐1β Gene Cluster and Preeclampsia

[1]  K. Kontula,et al.  677 C→T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and Preeclampsia , 2000, Obstetrics and gynecology.

[2]  D. Wing,et al.  Longitudinal evaluation of activated protein C resistance among normal pregnancies of Hispanic women. , 2000, American journal of obstetrics and gynecology.

[3]  G. Block,et al.  Will genetics revolutionize medicine? , 2000, The New England journal of medicine.

[4]  J. Martin,et al.  Expression of the placental cytokines tumor necrosis factor α, interleukin 1β, and interleukin 10 is increased in preeclampsia ☆ ☆☆ ★ , 1999 .

[5]  C. Mittermayer,et al.  Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[6]  B. Mazières,et al.  Interleukin‐1β, interleukin‐1 receptor antagonist, interleukin‐4, and interleukin‐10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritis , 1999 .

[7]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[8]  K. Ward,et al.  New insights into the genetics of preeclampsia. , 1999, Seminars in perinatology.

[9]  J. N. Martin,et al.  Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. , 1999, American journal of obstetrics and gynecology.

[10]  M. Hurme,et al.  IL‐1 receptor antagonist (IL‐1Ra) plasma levels are co‐ordinately regulated by both IL‐1Ra and IL‐1β genes , 1998 .

[11]  J. Montero,et al.  T235 variant of the angiotensinogen gene and blood pressure in the Chilean population , 1998, Journal of hypertension.

[12]  Santtila,et al.  Presence of the IL‐1RA Allele 2 (IL1RN*2) is Associated with Enhanced IL‐1β Production In Vitro , 1998, Scandinavian journal of immunology.

[13]  M. Hurme,et al.  IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. , 1998, European journal of immunology.

[14]  C. Dinarello,et al.  Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.

[15]  D Paladini,et al.  Factor V Leiden, C>T MTHFR Polymorphism and Genetic Susceptibility to Preeclampsia , 1997, Thrombosis and Haemostasis.

[16]  C. Akdis,et al.  Plasma interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist levels in pre-eclampsia , 1997 .

[17]  K. Conrad,et al.  Placental Cytokines and the Pathogenesis of Preeclampsia , 1997, American journal of reproductive immunology.

[18]  C. Akdis,et al.  Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[19]  G. Chen,et al.  Tumour necrosis factor‐alpha (TNF‐α) gene polymorphism and expression in pre‐eclampsia , 1996 .

[20]  G. Chen,et al.  Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. , 1996, Clinical and experimental immunology.

[21]  J. Crusius,et al.  Allelic polymorphism in IL‐1β and IL‐1 receptor antagonist (IL‐1Ra) genes in inflammatory bowel disease , 1995, Clinical and experimental immunology.

[22]  D. Grennan,et al.  Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.

[23]  I. Greer,et al.  Increased concentrations of dytokines interleukin and interleukin‐1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? , 1994, Obstetrics and gynecology.

[24]  C. Dinarello,et al.  The interleuldn-1 family: 10 years of discovery’ , 2004 .

[25]  G. Duff,et al.  A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist Genes , 1994 .

[26]  G. Duff,et al.  A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. , 1994, Genomics.

[27]  J. Lalouel,et al.  A molecular variant of angiotensinogen associated with preeclampsia , 1993, Nature Genetics.

[28]  A. Blakemore,et al.  Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). , 1992, Human molecular genetics.

[29]  A. Blakemore,et al.  Single base polymorphism at −511 in the human interleukin-1β gene (IL1β) , 1992 .

[30]  F. Pociot,et al.  A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .

[31]  F. Pociot,et al.  A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. , 1992, European journal of clinical investigation.

[32]  W. Arend.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. , 1991, The Journal of clinical investigation.

[33]  M. T. Brewer,et al.  Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. , 1991, Proceedings of the National Academy of Sciences of the United States of America.